Company Valuation: Zhongzhi Pharmaceutical Holdings Limited

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization 1 968.7 1,181 696.5 832.7 1,113 803.4
Change - 21.94% -41.03% 19.55% 33.68% -27.82%
Enterprise Value (EV) 1 708 1,058 614.4 607.8 1,096 792.3
Change - 49.45% -41.93% -1.07% 80.26% -27.69%
P/E ratio 8.38x 8.41x 13.4x 7.68x 6.78x 8.46x
PBR 1.27x 1.44x 0.77x 0.83x 1.06x 0.72x
PEG - 0.4x -0.2x 0x 0.1x -0.2x
Capitalization / Revenue 0.72x 0.74x 0.4x 0.46x 0.54x 0.36x
EV / Revenue 0.53x 0.66x 0.35x 0.33x 0.53x 0.36x
EV / EBITDA 4.25x 5.07x 5.02x 3.95x 5.1x 4.6x
EV / EBIT 5.18x 7.14x 7.72x 5.87x 6.68x 6.33x
EV / FCF 11.2x -27.9x -12.5x 2.74x -10.5x 28.7x
FCF Yield 8.92% -3.58% -8.03% 36.4% -9.5% 3.48%
Dividend per Share 2 0.0541 0.0312 - 0.0531 0.0817 0.047
Rate of return 4.69% 2.22% - 5.5% 6.34% 5.05%
EPS 2 0.1376 0.1671 0.06 0.1256 0.19 0.11
Distribution rate 39.3% 18.6% - 42.3% 43% 42.7%
Net sales 1 1,342 1,604 1,746 1,826 2,050 2,215
EBITDA 1 166.5 208.6 122.3 153.9 214.8 172.3
EBIT 1 136.8 148.2 79.58 103.5 163.9 125.1
Net income 1 114.7 138.5 52.13 106.4 162.8 95.21
Net Debt 1 -260.7 -123.1 -82.1 -224.8 -17.45 -11.09
Reference price 2 1.1532 1.4062 0.8065 0.9642 1.2889 0.9303
Nbr of stocks (in thousands) 8,40,000 8,40,000 8,63,600 8,63,600 8,63,600 8,63,600
Announcement Date 14/04/20 14/04/21 19/04/22 20/04/23 19/04/24 16/04/25
1CNY in Million2CNY
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 8.64Cr
34.9x6.42x22.52x0.89% 4.26TCr
14.79x1.88x7.79x1.53% 3.13TCr
25.45x3.57x16.94x1.09% 1.16TCr
19.32x3.34x12.38x0.79% 965.98Cr
17.53x3.11x11.43x3.67% 798.77Cr
81.64x - - 1.1% 786.91Cr
16.03x2.02x8x3.41% 681.2Cr
24.43x3.29x15.36x0.14% 604.39Cr
Average 29.26x 3.37x 13.49x 1.58% 1.38TCr
Weighted average by Cap. 28.02x 4.01x 15.16x 1.36%
See all sector valuations

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 3737 Stock
  4. Valuation Zhongzhi Pharmaceutical Holdings Limited